- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04685551
Improving Survivorship Among Minority Cancer Dyads
July 22, 2022 updated by: Charles Drew University of Medicine and Science
Improving Survivorship Outcomes for African American and Latinx Cancer Survivors and Caregiver Dyads Through A Culturally Based Training Program for Underserved Health Professional Students
This proposed intervention centers on improving survivorship outcomes among African American and Latinx cancer survivor and caregiver dyads.
As a result, there will be four major outcomes.
First, as a result of partnership with minority social institutions (e.g.
faith leaders), we will develop an in-depth culturally sensitive curriculum and survivorship care plan for Cancer Survivorship and Caregiver Leaders Aimed for Minority Populations (CSC LAMPs).
Second, we will increase knowledge and skills by evaluating a comprehensive cancer survivorship training program designed for underserved health professional students.
Third, the implementation of this program will improve survivorship outcomes among African American and Latinx cancer survivors with advanced stage cancer and their caregivers.
Lastly, this study will build sustainability for underserved minorities with the training of 30 future healthcare providers as a valuable community resource for improving cancer survivorship outcomes.
The long-term outcomes of the CSC LAMPs program will generate workforce capacity and diversity in cancer-based clinical practice, research, and community advocacy for underserved minority cancer survivors and caregivers.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90059
- Charles R. Drew University of Medicine & Science
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Aim 1 Focus Group for Cancer Survivors and Caregivers:
Inclusion Criteria
- Individuals ages 18 and older
- identify as African American or Latinx
- identify as a cancer survivor and/or caregiver
- speak and/or understand English
Exclusion Criteria
- individuals ages 17 years or younger
- does not identify as African American or Latinx
- unable to speak or understand English
- does not identify as a cancer survivor or caregiver
Aim 1 Focus Group for Oncology Healthcare Providers:
Inclusion Criteria
- Individuals ages 18 and older
- identify as a healthcare provider
- provide care to cancer patients in current provider role
- speak and/or understand English
Exclusion Criteria
- individuals ages 17 years or younger
- unable to speak or understand English
- does not provide care to cancer patients
- does not identify as a healthcare provider
Aim 2:
Inclusion Criteria
- Individuals ages 18 and older
- registered as a CDU student
- speak and/or understand English
- considered to be underserved, which include a) identifying as an underrepresented minority: Asian, Pacific Islander, African American, Hispanic, and Native American/Alaskan Native and/or b) from a medically underserved population (i.e. faced economic, cultural or linguistic barriers to health care)
Exclusion Criteria
- individuals ages 17 years or younger
- not registered as a CDU student
- unable to speak or understand English
- not considered to be underserved
For Aim 3:
Inclusion Criteria
- cancer survivor with a participating caregiver
- stage III or stage IV cancer diagnosis
- breast, lung, or colorectal cancer diagnosis
- identify as African American or Latinx
- speak and/or understand English
Exclusion Criteria
- individuals ages 17 years or younger
- does not identify as African American or Latinx
- unable to speak or understand English
- does not identify as a cancer survivor
- cancer survivor does not identify a caregiver
- does not have a breast, lung, or colorectal cancer diagnosis
- not diagnosed with a stage III or stage IV cancer diagnosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Survivorship Management among African American and Latinx Cancer Dyads
This arm will implement a "one group pre-test and posttest" design to improve health outcomes of African American and Latinx cancer survivors and caregivers in collaboration with health professional students trained as Cancer Survivorship and Caregiver Leaders Aimed for Minority Populations (CSC LAMPs).
|
Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to improve survivorship outcomes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Increase in psychosocial well-being using the Quality of Life: Short Form Health Survey and the Center for Epidemiologic Studies Depression Scale
Time Frame: 3 months
|
By comparison from baseline to post-intervention, there will be a 25% increase in the psychosocial well-being among study participants.
|
3 months
|
Reduction of barriers to symptom management Using the Symptom Distress Scale survey
Time Frame: 3 months
|
By comparison from baseline to post-intervention, there will be a 25% decrease in the barriers to symptom management among study participants.
|
3 months
|
3. Decrease in unmet needs Using the Barriers to Follow-Up Care Survey and Cancer Survivors Unmet Needs instrument
Time Frame: 3 months
|
By comparison from baseline to post-intervention, there will be a 25% decrease in the unmet needs among study participants.
|
3 months
|
Reduction in caregiver burden using the Caregiver reaction assessment (CRA) survey
Time Frame: 3 months
|
By comparison from baseline to post-intervention, there will be a 25% decrease in the caregiver burden among study participants.
|
3 months
|
5. Increase knowledge and utilization of supportive services using the Medical Outcomes Study Social Support Survey
Time Frame: 3 months
|
By comparison from baseline to post-intervention, there will be a 25% increase in the knowledge and utilization of supportive services among study participants.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Sharon Cobb, Charles R. Drew University of Medicine & Science
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
July 1, 2021
Primary Completion (Anticipated)
June 30, 2024
Study Completion (Anticipated)
December 31, 2024
Study Registration Dates
First Submitted
December 22, 2020
First Submitted That Met QC Criteria
December 22, 2020
First Posted (Actual)
December 28, 2020
Study Record Updates
Last Update Posted (Actual)
July 26, 2022
Last Update Submitted That Met QC Criteria
July 22, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CancerDyads
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
Clinical Trials on Change in knowledge, motivation, skills, and resources
-
Charles Drew University of Medicine and ScienceCompleted
-
Medical College of WisconsinNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Boston University Charles River CampusSan Francisco State UniversityCompleted
-
New York City Health and Hospitals CorporationCompletedObesity | Diet Habit
-
University of Southern CaliforniaCompletedLow Executive Function in ChildrenUnited States
-
Zealand University HospitalUniversity of Copenhagen; Danish Working Environment FundCompleted
-
Case Western Reserve UniversityUniversity of Southern CaliforniaActive, not recruitingKnowledge and Interpersonal Skills to Develop Exemplary Relationships (KINDER): Pilot Study (KINDER)Dementia | Caregiver Burden | Elder Abuse | Relation, FamilyUnited States
-
Massachusetts General HospitalFenway Community HealthUnknownCrystal Methamphetamine Abuse | Crystal Methamphetamine DependenceUnited States
-
University GhentUniversity Hospital, Ghent; AZ Sint-Jan AV; Algemeen Ziekenhuis Maria Middelares and other collaboratorsCompletedHealthy Volunteers | Aortic Aneurysm, AbdominalBelgium
-
JhpiegoCompletedTraining | Satisfaction | Capacity Building